NO984016L - Ïyeblikkelig frigivelses pH-avhengig fast doseringsform av cisaprid - Google Patents

Ïyeblikkelig frigivelses pH-avhengig fast doseringsform av cisaprid

Info

Publication number
NO984016L
NO984016L NO984016A NO984016A NO984016L NO 984016 L NO984016 L NO 984016L NO 984016 A NO984016 A NO 984016A NO 984016 A NO984016 A NO 984016A NO 984016 L NO984016 L NO 984016L
Authority
NO
Norway
Prior art keywords
cisapride
dosage form
solid dosage
immediate release
dependent solid
Prior art date
Application number
NO984016A
Other languages
English (en)
Norwegian (no)
Other versions
NO984016D0 (no
Inventor
Paul Marie Victor Gilis
Guido Franciscus Smans
Guido Jozef Maria Gijs
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO984016D0 publication Critical patent/NO984016D0/no
Publication of NO984016L publication Critical patent/NO984016L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO984016A 1996-04-23 1998-09-01 Ïyeblikkelig frigivelses pH-avhengig fast doseringsform av cisaprid NO984016L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201078 1996-04-23
PCT/EP1997/001462 WO1997039744A1 (fr) 1996-04-23 1997-03-20 Forme galenique solide de cisapride independante du ph a liberation immediate

Publications (2)

Publication Number Publication Date
NO984016D0 NO984016D0 (no) 1998-09-01
NO984016L true NO984016L (no) 1998-12-23

Family

ID=8223900

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984016A NO984016L (no) 1996-04-23 1998-09-01 Ïyeblikkelig frigivelses pH-avhengig fast doseringsform av cisaprid

Country Status (23)

Country Link
US (1) US6030988A (fr)
JP (1) JPH10510559A (fr)
KR (1) KR100204115B1 (fr)
CN (1) CN1216467A (fr)
AR (1) AR006790A1 (fr)
AT (1) ATE220543T1 (fr)
AU (1) AU720582B2 (fr)
BG (1) BG102812A (fr)
BR (1) BR9708585A (fr)
CA (1) CA2201264C (fr)
CZ (1) CZ332598A3 (fr)
DE (1) DE69713948D1 (fr)
EA (1) EA000804B1 (fr)
EE (1) EE03552B1 (fr)
ID (1) ID16666A (fr)
IL (1) IL125979A0 (fr)
NO (1) NO984016L (fr)
NZ (1) NZ331705A (fr)
PL (1) PL328917A1 (fr)
SK (1) SK144698A3 (fr)
TR (1) TR199802139T2 (fr)
WO (1) WO1997039744A1 (fr)
ZA (1) ZA973449B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US20030138485A1 (en) * 1998-01-14 2003-07-24 Daiichi Pharmaceutical Co., Ltd. Disintegrant
EP1004305B1 (fr) * 1998-04-20 2011-09-28 Eisai R&D Management Co., Ltd. Compositions stabilisees contenant des composes du type benzimidazole
TW407058B (en) * 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
US6353005B1 (en) * 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
DE60036014T2 (de) 1999-10-20 2008-04-30 Eisai R&D Management Co., Ltd. Methode zur stabilisierung von benzimidazol-verbindungen
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
SE0100200D0 (sv) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US7714006B1 (en) 2001-12-03 2010-05-11 King Pharmaceuticals Research & Development, Inc. Methods of modifying the bioavailability of metaxalone
US6407128B1 (en) 2001-12-03 2002-06-18 Elan Pharmaceuticals, Inc. Method for increasing the bioavailability of metaxalone
DE10164510A1 (de) 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
EP1321142A1 (fr) * 2001-12-21 2003-06-25 Novartis AG Forme solide pour l'administration orale du Tégaserode
HRP20020124A2 (en) * 2002-02-11 2003-10-31 Pliva D D Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
GB2390541A (en) * 2002-07-12 2004-01-14 Reckitt Benckiser Healthcare Medicinal composition comprising fibre or saccharide bulking agents
AU2003276688A1 (en) * 2002-09-02 2004-03-19 Sun Pharmaceutical Industries Limited Pharmaceutical composition of metaxalone with enhanced oral bioavailability
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
MXPA06000524A (es) * 2003-07-18 2006-08-11 Santarus Inc Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido.
TWI398273B (zh) * 2003-07-18 2013-06-11 Santarus Inc 用於抑制酸分泌之醫藥調配物及其製備及使用之方法
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8138204B2 (en) * 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
EP1718303A4 (fr) * 2004-02-10 2010-09-01 Santarus Inc Combinaison d'un inhibiteur de la pompe a protons, d'un tampon et d'un medicament anti-inflammatoire non steroidien
AU2005249367A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
ES2381495T3 (es) * 2005-05-26 2012-05-28 Teva Women's Health, Inc. Formas de dosificación oral que comprenden progesterona y métodos para fabricar y usar las mismas
CN1935264B (zh) * 2005-09-23 2010-05-05 北京德众万全医药科技有限公司 一种用于缓控释片的含有hpmc的新型复合辅料
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
TW200843802A (en) * 2007-02-09 2008-11-16 Drugtech Corp Compositions for improving gastrointestinal nutrient and drug absorption
CN104352465B (zh) * 2014-11-17 2017-04-12 成都新恒创药业有限公司 一种不含二氧化硅的琥珀酸普芦卡必利药物组合物及其制备方法
JP7222063B2 (ja) 2018-07-12 2023-02-14 四川海思科制▲薬▼有限公司 縮合三環性γ－アミノ酸誘導体の組成物及びその調製
CN109394711A (zh) * 2018-11-06 2019-03-01 威海贯标信息科技有限公司 一种酒石酸西尼必利片组合物
WO2023242796A1 (fr) * 2022-06-15 2023-12-21 Varoli Giovan Battista Boîte pour l'approvisionnement de produits alimentaires pour des utilisateurs dysphagiques

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962115A (en) * 1981-10-01 1990-10-09 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
EP1145715A3 (fr) * 1992-07-07 2004-05-19 Sepracor Inc. Procédés d'utilisation de cisapride pour le traitement du reflux gastro-sophagien et d'autres troubles
WO1994001111A1 (fr) * 1992-07-07 1994-01-20 Sepracor Inc. Procedes d'utilisation de cisapride (+) pour le traitement du reflux gastro-×sophagien et d'autres troubles
EP0707492A1 (fr) * 1993-07-06 1996-04-24 Merck & Co. Inc. Combinaisons d'agents anti-h 2? et d'agents de motilite gastro-intestinale
ES2136157T3 (es) * 1994-03-01 1999-11-16 Gerhard Gergely Producto granular o comprimido que contiene un sistema efervescente y una sustancia farmaceutica activa, asi como un procedimiento para su preparacion.
CH686865A5 (de) * 1994-06-15 1996-07-31 Gergely Gerhard Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung.
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release

Also Published As

Publication number Publication date
US6030988A (en) 2000-02-29
BR9708585A (pt) 1999-08-03
KR100204115B1 (ko) 1999-06-15
AU720582B2 (en) 2000-06-08
ID16666A (id) 1997-10-30
EA000804B1 (ru) 2000-04-24
NO984016D0 (no) 1998-09-01
KR970069038A (ko) 1997-11-07
CN1216467A (zh) 1999-05-12
AR006790A1 (es) 1999-09-29
SK144698A3 (en) 1999-05-07
CA2201264A1 (fr) 1997-10-23
NZ331705A (en) 1999-11-29
IL125979A0 (en) 1999-04-11
EE9800269A (et) 1999-02-15
TR199802139T2 (xx) 1999-03-22
AU2290497A (en) 1997-11-12
ATE220543T1 (de) 2002-08-15
DE69713948D1 (de) 2002-08-22
BG102812A (en) 1999-05-31
ZA973449B (en) 1998-10-22
EE03552B1 (et) 2001-12-17
CA2201264C (fr) 1999-08-10
PL328917A1 (en) 1999-03-01
JPH10510559A (ja) 1998-10-13
WO1997039744A1 (fr) 1997-10-30
EA199800861A1 (ru) 1999-02-25
CZ332598A3 (cs) 1999-01-13

Similar Documents

Publication Publication Date Title
NO984016D0 (no) Ïyeblikkelig frigivelses pH-avhengig fast doseringsform av cisaprid
FI954905L (fi) Kiinteä farmaseuttinen koostumus, joka sisältää täyteainetta, joka kykenee sitomaan vettä
BR9701304A (pt) Formulação de liberação prolongada
ATE264677T1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
NO980707D0 (no) Fremgangsmåte til fremstilling av kopolymerer
DK0746310T3 (da) Præparat med styret afgivelse
ID18427A (id) Pengkabut serbuk
ATE253371T1 (de) Formulierungen von clarithromycin mit verlängerter wirkstoff-freisetzung
NO985694D0 (no) Fremstilling av stereoregulerte polymerer
DE69703902D1 (de) Strahlungsempfindliche Zusammensetzung
NO20002126L (no) Formulering med forlenget frigjøring
ID17860A (id) Komposisi vaksin
DK0975348T3 (da) Stabiliserede tibolon-sammensætninger
BR9509565A (pt) Composições orais de liberação prolongada de cisaprida
DE69717034D1 (de) Lippenstift Präparat
NO984035D0 (no) Farmas°ytiske formuleringer med sakte frigivelse inneholdende mizolastin
DE69823490D1 (de) Antitranspirant präparat
ID17419A (id) Komposisi dekafluoropentana
DE69615586D1 (de) Polyelektrolyte enthaltende zusammensetzungen
GB9600390D0 (en) Preparation of tablets
NO991148D0 (no) Fremstilling av 1-butyl-4-piperidinyl-metylamin
NO985110D0 (no) Eksplosivformuleringer
HUP9902179A3 (en) Pharmaceutical composition comprising immediate release ph-independent solid dosage form of cisapride
NO985112D0 (no) Eksplosivformuleringer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application